News Center

Actual patient. Results may vary. Actual patient. Results may vary.
Follow Us @AllerganAesthetics

Allergan Aesthetics Completes Acquisition of Soliton

<p>Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the successful completion of its acquisition of Soliton, Inc. (NASDAQ: SOLY). The addition of Soliton and its technology...</p> …

Allergan Aesthetics To Present Data From Its Leading Aesthetic Portfolio At The 2021 American Society For Dermatologic Surgery Virtual Meeting

<p>Allergan Aesthetics, an AbbVie company, (NYSE: ABBV) today announced that it will present six abstracts from its leading portfolio of aesthetic treatments and products at the American Society for...</p> …

Allergan Aesthetics Celebrates Third Annual BOTOX® Cosmetic (onabotulinumtoxina) Day

<p>Let the countdown begin. Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8966951-allergan-aesthetics-alle-botox-cosmetic-day/ Allergan...</p> …

Allergan Aesthetics Launches Series of Initiatives to Support Breast Cancer Awareness

<p>Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is continuing its commitment to breast health, awareness, restoration, and research in support of breast cancer awareness month. For the month...</p> …

DREAM™ Initiative Releases, The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas

Allergan Aesthetics, an AbbVie company, and SkinBetter Science through their DREAMTM (Driving Racial Equity in Aesthetic Medicine) initiative are supporting the development and distribution of The …

Allergan Aesthetics Continues Partnership with Girls Inc. to Empower Confidence in High School-Aged Girls Interested in STEM

Today Allergan Aesthetics, now an AbbVie company, announces its third consecutive year of partnership with Girls Inc. and debut of its Empowering Confidence Workshops, a nationwide mentoring …

Allergan Aesthetics and BOTOX® Cosmetic (onabotulinumtoxinA) Put Real Stories at the Forefront in New Campaign

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is changing the way BOTOX® Cosmetic, the #1 selling neurotoxin treatment1, is connecting with consumers. Today, the brand is launching 'See …

Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio

Allergan Aesthetics, an AbbVie company (NYSE: ABBV) and Soliton (NASDAQ: SOLY) today announced a definitive agreement under which Allergan Aesthetics will acquire Soliton and RESONICTM, its Rapid …

SkinMedica® Launches Neck Correct Cream for Neck and Décolleté

Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the launch of SkinMedica® Neck Correct Cream, the first product from the professional-grade skincare line formulated to …

CoolSculpting® by Allergan Aesthetics Expands Body Contouring Portfolio With CoolSculpting® Elite

Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the launch of CoolSculpting® Elite, its next generation fat reduction system with applicators designed to complement the …

Allergan Aesthetics and Allergan, an AbbVie Company, to Present 16 Neurotoxin Research Abstracts Across Multiple Therapeutic and Cosmetic Indications at the TOXINS 2021 Virtual Conference

Allergan Aesthetics and Allergan, an AbbVie company (NYSE: ABBV), announced today that scientific and clinical experts in the field of neurotoxins will present results from 16 abstracts spanning …

Allergan Aesthetics Enters Into Option to Acquire Cypris Medical

Today Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced that it has entered into a warrant agreement with Cypris Medical, a privately held, medical device company based in Chicago …

Allergan Aesthetics Celebrates Second Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is celebrating its second annual BOTOX® Cosmetic Day on Wednesday, November 18, 2020. The event is dedicated to celebrating the iconic …

Allergan Aesthetics To Present Data From 4 Abstracts At The 2020 American Society For Dermatologic Surgery Virtual Meeting

Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced today that it will present 4 abstracts at the annual American Society for Dermatologic Surgery (ASDS) virtual meeting from …

Allergan Aesthetics, an AbbVie Company, Acquires Innovative Luminera Dermal Filler Business

Today Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced that it has entered into an agreement with Luminera, a privately held, aesthetics company based in Israel with a portfolio and …

SkinMedica® Launches TNS® Advanced+ Pro-Infusion Serum for DiamondGlow™

Today Allergan Aesthetics, an AbbVie company, announced the launch of SkinMedica® TNS® Advanced+ Pro-Infusion Serum for DiamondGlow™ treatments. Offered by dermatologists, plastic surgeons and …

Malin Akerman Joins CoolSculpting® and CoolTone™ as U.S. Ambassador for the Allergan Aesthetics Body Contouring Portfolio

Today Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the partnership between actress and producer Malin Akerman and the Allergan Aesthetics body contouring portfolio. Akerman is …

Allergan Aesthetics and Skinbetter Science Announce The DREAM Initiative™ To Advance Health Equity and Diversity in Aesthetics

Today Allergan Aesthetics, an AbbVie company (NYSE: ABBV), and Skinbetter Science® announced the launch of a new long-term, educational initiative – DREAM: Driving Racial Equity in Aesthetic …

FDA Approves JUVÉDERM® VOLUMA™ XC for Enhancement of the Chin Region

Today Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the FDA approval of JUVÉDERM® VOLUMA™ XC for the augmentation of the chin region to improve the chin profile in adults over …

Allergan Aesthetics Launches Dedicated Multi-Channel Campaign To Contact Patients Who May Not Be Aware Of The BIOCELL® Recall And To Improve Tracking Information For U.S. Breast Implant Patients

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is initiating a new digital campaign to improve device tracking and further identify and reach breast implant patients who have, or have had, …

AbbVie Completes Transformative Acquisition of Allergan

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, announced today that it has completed its acquisition of Allergan plc following receipt of regulatory approval from all …

AbbVie Announces Leadership Team and Creation of New Business, Allergan Aesthetics, Upon Completion of Acquisition

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced the creation of a new global business, Allergan Aesthetics, an AbbVie company, and the proposed leadershipAbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced the creation of a new global business, Allergan Aesthetics, an AbbVie company, and the proposed leadership …

SkinMedica® Launches New Instant Bright Eye Cream For Immediate, Visible Results

…

BOTOX® Cosmetic (onabotulinumtoxinA) Launches Be The Difference Philanthropic Program

…